SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

世界の経口インスリン市場：規模、予測、COVID-19の影響分析（2021-2025年）

世界の経口インスリン市場：規模、予測、COVID-19の影響分析（2021-2025年）Global Oral Insulin Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)

このレポートへお問合せ

  
種別英文調査報告書
出版Daedal Research
出版年月2021年4月
ページ数83
図表数
価格（USD）
シングルユーザライセンス900
エンタープライズライセンス1500
 

レポート目次

  Report DetailsScope of the ReportThe report titled “Global Oral Insulin Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the global oral insulin market by value, by region, etc. The report provides a regional analysis of the oral insulin market, including the following regions: North America (The US, Mexico, and Canada); Europe (Germany, UK, France, Italy, Spain, and Rest of Europe); Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific); and ROW (Brazil, Saudi Arabia, South Africa, and ROW Countries). The report also provides a detailed analysis of the COVID-19 impact on the oral insulin market.The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global oral insulin market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.The global oral insulin market is consolidated with few major market players operating worldwide. The key players of the oral insulin market are Novo Nordisk A/S, Oramed Pharmaceuticals Inc., vTv Therapeutics, and Diabetology Ltd. are also profiled with their financial information and respective business strategies.Country CoverageNorth AmericaEuropeAsia PacificRest of WorldCompany CoverageNovo Nordisk A/SOramed Pharmaceuticals Inc.vTv TherapeuticsDiabetology Ltd.? Executive SummaryThe oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.The oral insulin market can be segmented on the basis of application (Type 1 diabetes and Type 2 diabetes); and gender (Female and Male).The global oral insulin market has increased significantly during the years 2019-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The oral insulin market is expected to increase due to rapid urbanization, escalating healthcare spending, increasing prevalence of diabetes, favorable government initiatives, advantages of oral insulin over injectable insulin, etc. Yet the market faces some challenges such as uncertainty around getting the FDA approval, low oral bioavailability, etc. Table of Contents

目次

1. Executive Summary2. Introduction2.1 Diabetes Mellitus: An Overview2.2 Insulin: An Overview2.2.1 Kinds of Insulin Formulations2.3 Oral Insulin: An Overview2.3.1 Types of Oral Insulin2.3.2 Advantages of Oral Insulin Treatment2.4 Oral Insulin Segmentation: An Overview2.4.1 Oral Insulin Segmentation3. Global Market Analysis3.1 Global Oral Insulin Market: An Analysis3.1.1 Global Oral Insulin Market by Value3.1.2 Global Oral Insulin Market by Region (North America, Europe, Asia Pacific, and Rest of World)4. Regional Market Analysis4.1 North America Oral Insulin Market: An Analysis4.1.1 North America Oral Insulin Market by Value4.1.2 North America Oral Insulin Market by Region (The US, Mexico, and Canada)4.1.3 The US Oral Insulin Market by Value4.1.4 Canada Oral Insulin Market by Value4.1.5 Mexico Oral Insulin Market by Value4.2 Europe Oral Insulin Market: An Analysis4.2.1 Europe Oral Insulin Market by Value4.2.2 Europe Oral Insulin Market by Region (Germany, UK, France, Italy, Spain, and Rest of Europe)4.2.3 Germany Oral Insulin Market by Value4.2.4 UK Oral Insulin Market by Value4.2.5 France Oral Insulin Market by Value4.2.6 Italy Oral Insulin Market by Value4.2.7 Spain Oral Insulin Market by Value4.2.8 Rest of Europe Oral Insulin Market by Value4.3 Asia Pacific Oral Insulin Market: An Analysis4.3.1 Asia Pacific Oral Insulin Market by Value4.3.2 Asia Pacific Oral Insulin Market by Region (China, Japan, India, Australia, South Korea and Rest of Asia Pacific)4.3.3 China Oral Insulin Market by Value4.3.4 Japan Oral Insulin Market by Value4.3.5 India Oral Insulin Market by Value4.3.6 Australia Oral Insulin Market by Value4.3.7 South Korea Oral Insulin Market by Value4.3.8 Rest of Asia Pacific Oral Insulin Market by Value4.4 ROW Oral Insulin Market: An Analysis4.4.1 ROW Oral Insulin Market by Value4.4.2 ROW Oral Insulin Market by Region (Brazil, Saudi Arabia, South Africa, and ROW countries)4.4.3 Brazil Oral Insulin Market by Value4.4.4 Saudi Arabia Oral Insulin Market by Value4.4.5 South Africa Oral Insulin Market by Value4.4.6 ROW Countries Oral Insulin Market by Value5. Impact of COVID-195.1 Impact of COVID-195.1.1 Impact of COVID-19 on Healthcare Sector5.1.2 Impact of COVID-19 on Diabetic Patients5.1.3 Impact of COVID-19 on Oral Insulin6. Market Dynamics6.1 Growth Driver6.1.1 Rapid Urbanization6.1.2 Increasing Prevalence of Diabetes6.1.3 Escalating Healthcare Spending6.1.4 Favorable Government Initiatives6.1.5 Advantages of Oral Insulin over Injectable Insulin6.2 Challenges6.2.1 Uncertainty around Getting the FDA Approval6.2.2 Low Oral Bioavailability6.3 Market Trends6.3.1 Increasing Demand for Oral Spray6.3.2 Growing Use of Oral Insulin Capsule for the Treatment of Nonalcoholic Steatohepatitis (NASH)6.3.3 Innovations in the Delivery of Oral Insulin7. Competitive Landscape7.1 Global Oral Insulin Market Players: A Financial Comparison7.2 Global Oral Insulin Market Players by Oral Drugs-related Clinical Trials8. Company Profiles8.1 Novo Nordisk A/S8.1.1 Business Overview8.1.2 Financial Overview8.1.3 Business Strategy8.2 Oramed Pharmaceuticals Inc.8.2.1 Business Overview8.2.2 Financial Overview8.2.3 Business Strategy8.3 vTv Therapeutics8.3.1 Business Overview8.3.2 Financial Overview8.3.3 Business Strategy8.4 Diabetology Ltd8.4.1 Business OverviewList of FiguresFigure 1: Kinds of Insulin FormulationsFigure 2: Types of Oral InsulinFigure 3: Oral Insulin SegmentationFigure 4: Global Oral Insulin Market by Value; 2019-2020 (US$ Billion)Figure 5: Global Oral Insulin Market by Value; 2021-2025 (US$ Billion)Figure 6: Global Oral Insulin Market by Region; 2020 (Percentage, %)Figure 7: North America Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 8: North America Oral Insulin Market by Value; 2021-2025 (US$ Billion)Figure 9: North America Oral Insulin Market by Region; 2020 (Percentage, %)Figure 10: The US Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 11: The US Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 12: Canada Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 13: Canada Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 14: Mexico Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 15: Mexico Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 16: Europe Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 17: Europe Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 18: Europe Oral Insulin Market by Region; 2020 (Percentage, %)Figure 19: Germany Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 20: Germany Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 21: UK Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 22: UK Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 23: France Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 24: France Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 25: Italy Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 26: Italy Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 27: Spain Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 28: Spain Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 29: Rest of Europe Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 30: Rest of Europe Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 31: Asia Pacific Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 32: Asia Pacific Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 33: Asia Pacific Oral Insulin Market by Region; 2020 (Percentage, %)Figure 34: China Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 35: China Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 36: Japan Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 37: Japan Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 38: India Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 39: India Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 40: Australia Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 41: Australia Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 42: South Korea Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 43: South Korea Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 44: Rest of Asia Pacific Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 45: Rest of Asia Pacific Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 46: ROW Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 47: ROW Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 48: ROW Oral Insulin Market by Region; 2020 (Percentage, %)Figure 49: Brazil Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 50: Brazil Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 51: Saudi Arabia Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 52: Saudi Arabia Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 53: South Africa Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 54: South Africa Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 55: ROW Countries Oral Insulin Market by Value; 2019-2020 (US$ Million)Figure 56: ROW Countries Oral Insulin Market by Value; 2021-2025 (US$ Million)Figure 57: Global Urban Population by Group of Economies; 2014-2050 (Million)Figure 58: Global Number of People Suffering from Diabetes; 2011-2030 (Million)Figure 59: Global Healthcare Spending; 2017-2022 (US$ Billion)Figure 60: Novo Nordisk A/S Net Sales; 2016-2020 (US$ Billion)Figure 61: Novo Nordisk A/S Net Sales by Segments; 2020 (Percentage, %)Figure 62: Novo Nordisk A/S Net Sales by Region; 2020 (Percentage, %)Figure 63: Oramed Pharmaceuticals Inc. Revenues; 2017-2020 (US$ Thousand)Figure 64: vTv Therapeutics Revenue; 2018-2020 (US$ Million)Table 1: Global Oral Insulin Market Players: A Financial Comparison; 2020Table 2: Global Oral Insulin Market Players by Oral Drugs-related Clinical Trials; 2019

お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    プライバシーポリシーはこちらをご覧ください。

    その他の最新記事8件